Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |